News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
839,891 Results
Type
Article (86045)
Company Profile (651)
Press Release (753195)
Section
Business (232472)
Career Advice (4123)
Deals (39703)
Drug Delivery (127)
Drug Development (90838)
Employer Resources (195)
FDA (18029)
Job Trends (17303)
News (395980)
Policy (39666)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (9)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2982)
Academic (1)
Accelerated approval (3)
Adcomms (26)
Allergies (83)
Alliances (56712)
ALS (83)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (123)
Approvals (17993)
Artificial intelligence (248)
Autoimmune disease (13)
Automation (14)
Bankruptcy (399)
Best Places to Work (12616)
BIOSECURE Act (21)
Biosimilars (104)
Biotechnology (448)
Bladder cancer (54)
Brain cancer (26)
Breast cancer (242)
Cancer (1890)
Cardiovascular disease (154)
Career advice (3524)
Career pathing (32)
CAR-T (147)
Cell therapy (418)
Cervical cancer (14)
Clinical research (72699)
Collaboration (752)
Compensation (400)
Complete response letters (27)
COVID-19 (2839)
CRISPR (38)
C-suite (193)
Cystic fibrosis (103)
Data (1751)
Decentralized trials (2)
Denatured (41)
Depression (43)
Diabetes (231)
Diagnostics (6833)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (114)
Drug pricing (114)
Drug shortages (28)
Duchenne muscular dystrophy (69)
Earnings (95627)
Editorial (32)
Employer branding (25)
Employer resources (166)
Events (128573)
Executive appointments (612)
FDA (19035)
Featured Employer (69)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (667)
Gene editing (98)
Generative AI (25)
Gene therapy (297)
GLP-1 (773)
Government (5091)
Grass and pollen (4)
Guidances (46)
Healthcare (20833)
Huntington's disease (24)
IgA nephropathy (22)
Immunology and inflammation (104)
Indications (24)
Infectious disease (2963)
Inflammatory bowel disease (140)
Inflation Reduction Act (11)
Influenza (45)
Intellectual property (73)
Interviews (811)
IPO (17773)
IRA (48)
Job creations (5183)
Job search strategy (2860)
Kidney cancer (10)
Labor market (30)
Layoffs (521)
Leadership (19)
Legal (10081)
Liver cancer (74)
Lung cancer (274)
Lymphoma (123)
Machine learning (2)
Management (64)
Manufacturing (275)
MASH (61)
Medical device (14511)
Medtech (14516)
Mergers & acquisitions (22308)
Metabolic disorders (643)
Multiple sclerosis (64)
NASH (23)
Neurodegenerative disease (85)
Neuropsychiatric disorders (29)
Neuroscience (1904)
NextGen: Class of 2025 (7664)
Non-profit (5075)
Northern California (2259)
Now hiring (36)
Obesity (353)
Opinion (263)
Ovarian cancer (64)
Pain (77)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (19)
Patents (189)
Patient recruitment (83)
Peanut (50)
People (64840)
Pharmaceutical (133)
Pharmacy benefit managers (21)
Phase I (22432)
Phase II (31579)
Phase III (23773)
Pipeline (835)
Podcasts (115)
Policy (122)
Postmarket research (3551)
Preclinical (10056)
Press Release (72)
Prostate cancer (86)
Psychedelics (37)
Radiopharmaceuticals (262)
Rare diseases (368)
Real estate (7381)
Recruiting (74)
Regulatory (26447)
Reports (54)
Research institute (2647)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (1)
RSV (38)
Schizophrenia (68)
Series A (124)
Series B (73)
Service/supplier (27)
Sickle cell disease (55)
Southern California (1935)
Special edition (17)
Sponsored (33)
Startups (4284)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (73)
United States (20564)
Vaccines (727)
Venture capitalists (35)
Webinars (13)
Weight loss (264)
Women's health (35)
Worklife (16)
Date
Today (175)
Last 7 days (792)
Last 30 days (3107)
Last 365 days (36491)
2025 (6014)
2024 (37555)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1269)
Alabama (55)
Alaska (7)
Arizona (246)
Arkansas (13)
Asia (49800)
Australia (8782)
California (5255)
Canada (1788)
China (441)
Colorado (241)
Connecticut (252)
Delaware (119)
Europe (114068)
Florida (760)
Georgia (180)
Hawaii (1)
Idaho (64)
Illinois (534)
India (23)
Indiana (288)
Iowa (8)
Japan (129)
Kansas (106)
Kentucky (25)
Louisiana (10)
Maine (64)
Maryland (833)
Massachusetts (4104)
Michigan (214)
Minnesota (370)
Mississippi (2)
Missouri (73)
Montana (30)
Nebraska (26)
Nevada (56)
New Hampshire (64)
New Jersey (1492)
New Mexico (29)
New York (1488)
North Carolina (1012)
North Dakota (8)
Northern California (2259)
Ohio (184)
Oklahoma (14)
Oregon (44)
Pennsylvania (1175)
Puerto Rico (7)
Rhode Island (25)
South America (1649)
South Carolina (13)
South Dakota (1)
Southern California (1935)
Tennessee (84)
Texas (773)
Utah (159)
Virginia (129)
Washington D.C. (60)
Washington State (517)
West Virginia (3)
Wisconsin (47)
839,891 Results for "cellinfinity bio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Novel gene delivery technology published and licensed exclusively to Cellinfinity Bio
Cellinfinity Bio announced the publication of MAJESTIC, a technology that efficiently and with high cell health introduces genes into human genome, independent of CRISPR and lentiviral methods.
July 10, 2023
·
2 min read
Biotech Bay
Novel Chimeric Antigen Receptor Design Technology for CAR-T Cells Published and Licensed Exclusively to Cellinfinity Bio
Cellinfinity Bio, a privately held biotechnology company developing first/best-in-class cell therapy products against solid tumors and other diseases, today announced the publication of a novel CAR enhancement, the addition of CTLA-4 intracellular domain to improve anti-tumor CAR-T activity.
July 27, 2023
·
2 min read
Press Releases
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
February 5, 2025
·
3 min read
Press Releases
Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
February 4, 2025
·
3 min read
Press Releases
GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
·
5 min read
Press Releases
INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans
January 28, 2025
·
7 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
EditCo Bio, Inc. Launches XDel Knockout Cells: Redefining CRISPR Gene Editing Efficiency and Reproducibility
January 28, 2025
·
3 min read
Press Releases
Cadenza Bio, Inc. Announces Members of the Women’s Health Scientific Advisory Board
January 9, 2025
·
2 min read
Press Releases
89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
January 28, 2025
·
5 min read
1 of 83,990
Next
